Medical Fish Skin Company Kerecis Presents New Research at the Symposium on Advanced Wound Care
Kerecis Omega3 Wound is intact fish skin that, when grafted onto damaged human tissue, recruits the body’s own cells and ultimately is converted into living tissue. Because no disease-transfer risk exists between cold-water fish and humans, the Kerecis fish skin is only gently processed and retains its similarity to human skin, making it an ideal skin substitute. Fish skin also contains Omega3 fatty acids, which enhance wound healing.
“Fish skin is becoming a mainstream therapy for treating severe wounds, including diabetic or burn wounds,” said G. Fertram Sigurjonsson, founder and CEO of Kerecis. “These studies are part of the growing body of evidence affirming the efficacy of the Kerecis fish-skin wound treatment,” he added.
Kerecis will be presenting these five abstracts at SAWC Fall:
- CS-012: Effectiveness of Fish Skin Grafts in Chronic or Stalled Wounds (Brittnie Cave, NP)
- CS-015: A New Approach to the Management and Closure of Challenging Tunneling Wounds (Dr. John Cicero)
- CS-044: Closed Incision Sites and Skin Grafts: Use of Intact Fish Skin Graft with Omega3 on Atypical, Difficult-to-Heal Wounds (Lisa Jeffers, NP)
- CS-084: Clinical Observation of a Novel Fish Skin Graft in Reconstruction of a Complex Full-Thickness Wound (Dr. Mark Suski)
- PI-013: Success of Surgical Applications of a Novel Fish Skin Graft in Reconstruction of a Complex Full-Thickness Wound (Dr. Eric Lullove)
Taste of Iceland Event
Kerecis also invites SAWC attendees to join them on Sunday, October 13, from 7 to 9 p.m. for “A Taste of Iceland.” This popular dinner event will feature Dr. Ragnar Ingvarsson, who is a medical doctor by day and is known on the TV show as “the Doctor in the Kitchen” at night. He is also a best-selling cookbook author. Due to its popularity, a seat at this event is not guaranteed. Please register at the booth (527) or at https://www.kerecis.com/register-for-taste-of-iceland.
Kerecis is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid-rich products from the company’s patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring.
The Kerecis products, which are based on Omega3-rich fish skin, are currently being used to regenerate tissue in trauma and chronic wounds, such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications.
The company’s mission is to extend human life by supporting the body’s own ability to regenerate, and its vision is to become the world leader in tissue regeneration by sustainably harnessing nature’s own remedies. For more information, visit www.kerecis.com